It would seem to be a good sign that it’s almost September and they are still working on the metabolic trap hypothesis.Ha difficult question, maybe a 7
Last edited:
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
It would seem to be a good sign that it’s almost September and they are still working on the metabolic trap hypothesis.Ha difficult question, maybe a 7
We then talked about the metabolic trap and speculated about its potential causes and treatments, most of which have been covered publically (so I won't rehash here).
They are still testing it.
It'll be interesting to know how your blood, since you have improved dramatically, if it still shows the classical ME/CFS impedance signature.
Doesn't look like it yet @Gingergrrl according to the recent OMF Science Wednesday article.Do you know @dreampop (or Jesse) if Ron has tested patients with other conditions like POTS, MCAS, or various autoimmune diseases and if they have a different blood impedance signature than the ME/CFS patients?
From what I have read I don't think they can use Biobank samples due to special processing of the blood. This means that progress will likely be slow. In a recent update (Rons video maybe?) I believe that a paper on the nano-needle for ME/CFS will be submitted soon where we will learn more about how it all works.Since then I have spent many days and nights running experiments with the nanoneedle and studying the disease because I strongly believe there is always a way to find a solution if you try hard enough. Having that in mind and using our new technology, I spent months re-designing and micro-fabricating many more new sensors, and characterizing and calibrating them for this specific application. Then, for the first time, it was experimentally observed that ME/CFS blood cells display a characteristic impedance pattern when subjected to hyperosmotic stress that is significantly different to that of the healthy controls. The impedance pattern differences between ME/CFS and healthy blood in response to hyperosmotic stress suggest that the technology can potentially provide us with a unique indicator of ME/CFS. It’s very encouraging that the results thus far indicate that the technology can potentially establish a rapid and accurate diagnostic platform for ME/CFS while also providing insights into the biology of this complex disorder. Additionally, using this technology as a drug-screening tool, several small molecules have been tested to see how they can help ME/CFS cells to return to healthy cell behavior. These promising results suggest that the technology can potentially be used for rapidly screening candidate drugs and/or substances for ME/CFS.
Now, we are aiming to perform further experiments to understand the exact mechanisms contributing to the results and to test the performance of the assay on other diseases. Additionally, we are working on adapting the technology to a platform capable of pre-clinical testing of candidate drugs and therapies for ME/CFS patients, leading towards the development of a portable, handheld, and easy-to-use platform that can be operated by researchers and clinicians at any skill level.
I've never seen specifics on metabolic trap, I've just seen it referenced... Has anyone ever explained what the metabolic trap actually is, or which pathways are affected? thx